Eisai Establishes Pharmaceuticals Marketing Subsidiary in Italy

Eisai Co. Ltd. has announced that it has established a pharmaceuticals marketing subsidiary, Eisai S.r.l. (Eisai Societa a responsabilita limitata) in Italy on Feb. 21. Eisai S.r.l. is fully owned by Eisai Europe Ltd., and will sell and promote pharmaceuticals including Zonegran, an anti-epileptic drug whose MAA (marketing authorization application) has been submitted to EMEA (European Medicines Agency), and rufinamide, another anti-epileptic drug whose MAA is planned to be submitted in FY2004.

Investors.com (http://www.investors.com/breakingnews.asp?journalid=26134912&brk=1)